Clinical Practice Guidelines
2.0.0 - STU2 International flag

This page is part of the Clinical Guidelines (v2.0.0: STU2) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions

ActivityDefinition: CKD Referral Nephrology (Experimental)

Official URL: http://hl7.org/fhir/uv/cpg/ActivityDefinition/cc-cpg-activity-referral-nephrology Version: 2.0.0
Active as of 2024-11-26 Computable Name: ReferralNephrology
Other Identifiers: OID:2.16.840.1.113883.4.642.40.48.11.21

Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

Generated Narrative: ActivityDefinition cc-cpg-activity-referral-nephrology

CQF Knowledge capability: shareable

CQF Knowledge capability: computable

CQF Knowledge capability: publishable

url: ActivityDefinition ReferralNephrology

identifier: Uniform Resource Identifier (URI)/urn:oid:2.16.840.1.113883.4.642.40.48.11.21

version: 2.0.0

name: ReferralNephrology

status: Active

experimental: true

date: 2024-11-26 17:38:52+0000

publisher: HL7 International / Clinical Decision Support

contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss

description:

Referral: Nephrology; History: [add diagnosis, symptom(s)]; Question: [add reason for referral]

jurisdiction: World

relatedArtifact

type: Justification

display: Refer to nephrologist for co-management of treatment plan in cases of: Unclear etiology of kidney disease Rapid progression of disease (GFR decline greater than 5 mL/minute/1.73 m²/year) Acute kidney injury or abrupt sustained fall in GFR GFR less than 30 mL/minute/1.73 m² (GFR categories G4-G5) to prepare for renal replacement therapy Consistent finding of significant albuminuria (albumin/creatinine ratio of 300 mg/g or more) Hypertension resistant to treatment with 4 or more antihypertensive agents Difficulty in decreasing the level of albuminuria despite institution of ACE inhibitor or angiotensin II receptor blocker therapy Persistent electrolyte abnormalities, including hyperkalemia or high serum phosphate Recurrent or extensive nephrolithiasis Hereditary kidney disease   Nephrologist involvement is recommended when the cause of chronic kidney disease is not clear Renal biopsy may be performed to determine the cause as well as to predict disease progression and response to therapy

citation:

Chronic Kidney Disease Clinical Overview. ClinicalKey. Source

url: http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325

Documents

-Url
*http://himss19.ordersetsmanager.com/evidenceviewer/#/7CBBBE9B75E10232E05352E3610A5325/7CBBBE9B75DA0232E05352E3610A5325

kind: ServiceRequest

code: Referral to nephrologist

intent: Proposal

timing: Events: ??

Participants

-Type
*Practitioner